Orchestra BioMed (NASDAQ: OBIO) investors approve all 2026 meeting items
Filing Impact
Filing Sentiment
Form Type
8-K
Rhea-AI Filing Summary
Orchestra BioMed Holdings, Inc. reported the results of its 2026 Annual Meeting of Stockholders. Of 59,880,715 common shares entitled to vote as of April 28, 2026, 49,053,298 shares were represented, allowing stockholders to act on five proposals.
Stockholders elected three Class III directors, David P. Hochman, Darren R. Sherman, and Eric S. Fain, to serve until the 2029 annual meeting. They ratified Ernst & Young LLP as independent auditor for 2026, approved the 2026 equity incentive plan, and supported, on an advisory basis, the compensation of named executive officers. In an advisory vote on frequency of future say‑on‑pay votes, stockholders indicated a preference for holding this vote every one year, which the company intends to follow until the next required frequency vote, expected in 2032.
Positive
- None.
Negative
- None.
8-K Event Classification
Item 5.07 — Submission of Matters to a Vote of Security Holders
1 item
Item 5.07
Submission of Matters to a Vote of Security Holders
Governance
Results of a shareholder vote on proposals at an annual or special meeting.
Key Figures
Shares entitled to vote: 59,880,715 shares
Shares represented at meeting: 49,053,298 shares
Votes for Hochman: 39,724,691 votes
+4 more
7 metrics
Shares entitled to vote
59,880,715 shares
Common stock entitled to vote as of April 28, 2026 record date
Shares represented at meeting
49,053,298 shares
Common stock represented at the 2026 Annual Meeting
Votes for Hochman
39,724,691 votes
Election of director David P. Hochman, Proposal 1
Auditor ratification support
49,039,578 votes for
Ratification of Ernst & Young LLP for 2026
Equity plan approval
39,639,592 votes for
Approval of 2026 equity incentive plan
Say-on-pay support
37,975,986 votes for
Advisory vote on NEO compensation
One-year frequency support
38,995,022 votes
Preference for annual say-on-pay frequency
Key Terms
broker non-votes, independent registered public accounting firm, equity incentive plan, non-binding advisory vote, +1 more
5 terms
broker non-votes financial
"Director Name ... Votes Withheld ... Broker Non-Votes"
Broker non-votes occur when a brokerage firm is unable to vote on a shareholder’s behalf during a company election or decision because the shareholder has not given specific voting instructions, and the broker is not allowed or chooses not to vote on certain matters. They are important because they can affect the outcome of votes, especially when the results are close, by effectively reducing the total number of votes cast.
independent registered public accounting firm financial
"ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm"
An independent registered public accounting firm is an outside accounting company officially registered with the government regulator to examine and report on a public company's financial records and controls. Investors treat its reports like an impartial inspector’s certificate — they add credibility to financial statements, help spot errors or misleading claims, and reduce the risk that shareholders are relying on unchecked or biased numbers.
equity incentive plan financial
"The proposal to approve the Orchestra BioMed Holdings, Inc. 2026 Equity Incentive Plan"
An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.
non-binding advisory vote financial
"The advisory (non-binding) vote on the compensation of the Company’s named executive officers"
A non-binding advisory vote is a shareholder vote that expresses investors’ opinion on a proposal (such as executive pay, corporate policy, or governance practices) but does not legally force the company to act. Think of it like a customer survey: it signals whether owners approve or disapprove and can pressure boards and managers to change course, so investors watch the result as an indicator of governance risk and potential future shifts in company strategy or leadership.
record date financial
"were entitled to vote as of April 28, 2026, the record date for the Annual Meeting"
The record date is the specific day when a company determines which shareholders are eligible to receive a dividend or participate in an upcoming vote. It’s like a cutoff date; if you own the stock on that day, you get the benefits or voting rights. This date matters because it decides who qualifies for certain company benefits.
FAQ
Which directors were elected at Orchestra BioMed (OBIO)'s 2026 annual meeting?
Shareholders elected three Class III directors: David P. Hochman, Darren R. Sherman, and Eric S. Fain. Each will serve until the 2029 annual meeting and until a successor is duly elected and qualified, reflecting shareholder support for the existing board slate.
How often will Orchestra BioMed (OBIO) hold say-on-pay votes after the 2026 meeting?
Shareholders indicated a preference for an advisory vote on executive compensation every one year, with 38,995,022 votes favoring this frequency. The company intends to hold say-on-pay votes at each annual meeting until the next required frequency vote, expected in 2032.
Were there significant broker non-votes at Orchestra BioMed (OBIO)'s 2026 meeting?
Yes. Several proposals showed broker non-votes, including 9,231,589 broker non-votes on the director elections, the equity incentive plan, and the say-on-pay proposal. Broker non-votes generally arise when beneficial owners do not provide voting instructions on non-routine matters.